SATENIK MELKONYAN: Open Payments
NPI 1124662234 · LA MESA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$939 in 30 payments from 13 companies in 2025. Trend: 2023 $207 · 2024 $969 · 2025 $939
Food & beverage: $939
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 8 | $250 |
| Janssen Biotech, Inc. | 4 | $169 |
| PFIZER INC. | 2 | $97 |
| PROGENICS PHARMACEUTICALS, INC. | 3 | $72 |
| Smith+Nephew, Inc. | 2 | $68 |
| ABBVIE INC. | 3 | $66 |
| Telix Pharmaceuticals | 2 | $50 |
| Davol Inc. | 1 | $38 |
| Astellas Pharma US Inc | 1 | $32 |
| Procept Biorobotics Corporation | 1 | $26 |
Products named: GEMTESA, XTANDI, ERLEADA, PYLARIFY, RYBREVANT, ILLUCCIX, BOTOX, ARISTA.
Industry payments across CA — which companies pay providers there.
